Programmed Death 1 Lives Up to Its Reputation in Active Tuberculosis

Division of Tuberculosis Elimination, National Center for HIV/ AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
The Journal of Infectious Diseases (Impact Factor: 6). 05/2013; 208(4). DOI: 10.1093/infdis/jit211
Source: PubMed
Download full-text


Available from: Suraj B Sable, Dec 22, 2013
53 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: In many regions of the world, there is a great overlap between the prevalence of cigarette smoke exposure and tuberculosis. Despite the large body of epidemiologic evidence that tobacco smoke exposure is associated with increased tuberculosis infection, active disease, severity of disease, and mortality from tuberculosis, these studies cannot distinguish whether the mechanism is principally through direct impairment of anti-tuberculosis immunity by cigarette smoke or due to potential confounders that increase risk for tuberculosis and are commonly associated with smoking - such as poverty, malnutrition, and crowded living conditions. While there are several in vivo murine and in vitro macrophage studies showing cigarette smoke impairs control of tuberculous infection, little is known of the molecular and cellular mechanisms by which this impairment occurs. Herein, we highlight the key findings of these studies. Additionally, we review key immune cells that play critical roles in host-defense or pathogenesis of tuberculosis and generate a hypothesis-driven discussion of the possible mechanisms by which cigarette smoke impairs or enhances their functions, respectively, ultimately resulting in compromised immunity against tuberculosis.
    Tuberculosis (Edinburgh, Scotland) 09/2014; 94(6). DOI:10.1016/ · 2.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mycobacterium bovis bacille Calmette-Gué rin (BCG) is the most widely used live attenuated vaccine. However, the correlates of protection and waning of its immunity against tuberculosis is poorly understood. In this study, we correlated the longitudinal changes in the magnitude and functional quality of CD4 + and CD8 + T-cell response over a period of two years after mucosal or parenteral BCG vaccination with the strength of protection against Mycobacterium tuberculosis in mice. The BCG vaccination-induced CD4 + and CD8 + T cells exhibited comparable response kinetics but distinct functional attributes in-terms of IFN-c, IL-2 and TNF-a co-production and CD62L memory marker expression. Despite a near life-long BCG persistence and the induction of enduring CD4 + T-cell responses characterized by IFN-c and/or TNF-a production with comparable protection, the protective efficacy waned regardless of the route of vaccination. The progressive decline in the multifactorial functional abilities of CD4 + and CD8 + T cells in-terms of type-1 cytokine production, proliferation and cytolytic potential corresponded with the waning of protection against M. tuberculosis infection. In addition, simultaneous increase in the dysfunctional and terminally-differentiated T cells expressing CTLA-4, KLRG-1 and IL-10 during the contraction phase of BCG-induced response coincided with the loss of protection. Our results question the empirical development of BCG-booster vaccines and emphasize the pursuit of strategies that maintain superior T-cell functional capacity. Furthermore, our results underscore the importance of understanding the comprehensive functional dynamics of OPEN ACCESS
    PLoS ONE 11/2014; 9(11). DOI:10.1371/journal.pone.0113951 · 3.23 Impact Factor
  • The Journal of Infectious Diseases 03/2015; 211(6):1027-1029. DOI:10.1093/infdis/jiu532 · 6.00 Impact Factor